Factor Taking Part in Transcription Control
Abstract
HDART binds with HDAC (histone deacetylase) and function as a repressor. HDART directly binds with Skip functioning as a transcription co-activator of a nuclear receptor to repress the transcription of the nuclear receptor. Moreover, HDART is one of transcription co-repressors of nuclear receptor, and binds with HDAC thereby enabling intense repression of transcription through the histone deacetylization of HDAC. On the other hand, a dominant negative peptide of HDART can be obtained, and it has been confirmed that this peptide activates transcription contrary to the HDART protein of the full length. Especially, the transcription activity of retinoic acid receptor with this peptide has an activity exceeding all-trans retinoic acid (ATRA).
Claims
exact text as granted — not AI-modified1 . DNA coded with a transcription repressing factor including:
(A) DNA coded with a protein having an amino acid sequence indicated in Sequence No. 2; or (B) DNA consisting of a base sequence indicated in Sequence No. 1.
2 . DNA coded with a transcription repressing factor including:
(A) DNA coded with a protein having such an amino acid sequence that one or plural amino acids are substituted with, deleted from, inserted into and/or added to an amino acid sequence indicated in Sequence No. 2; or (B) DNA hybridized with DNA consisting of a base sequence indicated in Sequence No. 1 under stringent conditions.
3 . The transcription repressing factor coded with DNA as set forth in claim 1 or 2 .
4 . The transcription repressing factor as set forth in claim 3 wherein transcription ascribed to a nuclear hormone receptor is repressable.
5 . DNA coded with a peptide capable of activating transcription including:
(A) DNA coded with a peptide consisting of an amino acid sequence from position 1 to 179 in Sequence No. 2; or (B) DNA consisting of a base sequence of from 1 to 537 bases in Sequence No. 1.
6 . DNA coded with a peptide capable of activating transcription including:
(A) DNA coded with a peptide having such an amino acid sequence that one or plural amino acids are substituted with, deleted from, inserted into and/or added to an amino acid sequence position 1 to 179 in Sequence No. 2; or (B) DNA hybridized with DNA consisting of a base sequence position 1 to 537 bases in Sequence No. 1 under stringent conditions.
7 . The transcription activation peptide coded with the DNA as set forth in claim 5 or 6 .
8 . DNA as set forth in claim 1 , 2 , 5 or 6 and having at least 15 nucleotide length.
9 . A vector inserted with the DNA as set forth in claim 1 , 2 , 5 or 6 .
10 . A host cell holding the DNA as set forth in claim 1 , 2 , 5 or 6 .
11 . An antibody capable of binding with the factor as set forth in claim 3 .
12 . An oligonucleotide probe hybridized with the DNA as set forth in claim 1 , 2 , 5 or 6 and having at least 10 nucleotide length.
13 . A substrate fixed with the oligonucleotide probe as set forth in claim 12 .
14 . An antibody capable of binding with the peptide as set forth in claim 7 .
15 . A substrate fixed with the transcription repressing factor as set forth in claim 3 , or a partial peptide of said factor.
16 . A substrate fixed with the transcription activating factor as set forth in claim 3 , or a partial peptide of said factor.
17 . A substrate fixed with the antibody as set forth in claim 11 .Join the waitlist — get patent alerts
Track US2008145928A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.